Comparing patient-relevant endpoint with clinical endpoint in a rare disease: The case of metastatic Merkel cell carcinoma treated with avelumab Meeting Abstract
| Authors: | Bharmal, M.; Nolte, S.; Lebbe, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Pusceddu, S.; Hanna, G. J.; Hassel, J. C.; Kiecker, F.; Ellers-Lenz, B.; Bajars, M.; Guzel, G.; Nghiem, P.; Hunger, M.; Schlichting, M.; Henry-Szatkowski, M.; D'Angelo, S. P. |
| Abstract Title: | Comparing patient-relevant endpoint with clinical endpoint in a rare disease: The case of metastatic Merkel cell carcinoma treated with avelumab |
| Meeting Title: | ISPOR 2020 HEOR: Advancing Evidence to Action |
| Journal Title: | Value in Health |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 May 18-20 |
| Meeting Location: | Virtual |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2020-05-01 |
| Start Page: | S23 |
| Language: | English |
| ACCESSION: | WOS:000535812700097 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2020.04.1515 |
| Notes: | Meeting Abstract: PCN8 -- Source: Wos |
